Form 4: Liquidia Corp's Chief Medical Officer Rajeev Saggar Sells Shares to Cover Taxes
SEC Form 4 Filing
Liquidia Corp's Chief Medical Officer, Rajeev Saggar, sold shares of common stock to cover taxes associated with the settlement of restricted stock units.
Summary
- On October 18, 2024, Rajeev Saggar, the Chief Medical Officer of Liquidia Corp, sold 2,526 shares of common stock at a price of $11.19 per share.
- The sale was executed to cover taxes associated with the settlement of restricted stock units (RSUs) that were initially granted on July 18, 2022.
- Following the transaction, Saggar beneficially owns 204,857 shares of Liquidia Corp, which includes unvested RSUs from grants made on July 18, 2022, January 11, 2023, and January 11, 2024, as well as shares acquired under the 2020 Employee Stock Purchase Plan.
- The transaction was effected pursuant to a Rule 10b5-1 plan adopted on December 15, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects a routine transaction for tax purposes and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are routine disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and are closely watched by investors for signals about a company's prospects.
Key Dates
| Date | Description |
|---|---|
| July 18, 2022 | Initial grant date of restricted stock units (RSUs) that led to the tax obligation. |
| January 11, 2023 | Grant date of additional unvested RSUs held by Rajeev Saggar. |
| December 15, 2023 | Date Rajeev Saggar adopted the Rule 10b5-1 trading plan. |
| January 11, 2024 | Grant date of additional unvested RSUs held by Rajeev Saggar. |
| October 18, 2024 | Date of the stock sale transaction. |
| October 22, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.